A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response.
Weekers. Frank F; Van Herck. Erik E; Coopmans. Willy W; Michalaki. Marina M; Bowers. Cyril Y CY; Veldhuis. Johannes D JD; Van den Berghe. Greet G
Key Findings
- Critically ill rabbits had a doubled pulsatile GH secretion on day 1, which fell by day 8 despite low IGF‑I levels.
- GHRP‑2 + TRH provoked larger GH responses in sick rabbits, especially on day 8.
- TSH levels stayed the same, but thyroid hormones (T3/T4) were dramatically suppressed; prolactin secretion dropped only on day 8.
Practical Outcomes
- For biohackers, the study offers limited direct guidance. It suggests that GHRP‑2 can strongly boost GH during severe physiological stress, but the model is an illness scenario, not a normal or longevity‑focused setting. No dosing or safety recommendations for healthy individuals can be drawn from these results.
Summary
In a rabbit study of severe burns and prolonged critical illness, researchers used GHRP‑2 to test how the pituitary hormones GH, TSH and prolactin respond. They found that sick rabbits showed a temporary spike in GH release and an even bigger response to GHRP‑2 over time, while thyroid and prolactin hormones behaved differently. The work mainly shows how the body’s hormone system reacts to extreme stress, not how healthy people might use GHRP‑2.
Abstract
High doses of GH, used to induce anabolism in prolonged critically ill patients, unexpectedly increased mortality. To further explore underlying mechanisms, a valid animal model is needed. Such a model is presented in this study. Seven days after arterial and venous cannulae placement, male New Zealand White rabbits were randomly allocated to a control or a critically ill group. To induce prolonged critical illness, a template controlled 15% deep dermal burn injury was imposed under combined general and regional (paravertebral) anesthesia. Subsequently, critically ill rabbits received supplemental analgesia and were parenterally fed with glucose, insulin, amino acids, and lipids. On d 1 and d 8 after randomization, acute and chronic spontaneous hormonal profiles of GH, TSH, and PRL secretion were obtained by sampling blood every 15 min for 7 h. Furthermore, GH, TSH, and PRL responses to an iv bolus of GH-releasing peptide 2 (GHRP-2) + TRH were documented on d 0, 1, and 8. Hemodynamic status and biochemical parameters were evaluated on d 0, 1, 3, 5, and 8, after which animals were killed and relative wet weight and water content of organs was determined. Compared with controls, critically ill animals exhibited transient metabolic acidosis on d 1 and weight loss, organ wasting, systolic hypertension, and pronounced anemia on d 8. On d 1, pulsatile GH secretion doubled in the critically ill animals compared with controls, and decreased again on d 8 in the presence of low plasma IGF-I concentrations from d 1 to d 8. GH responses to GHRP-2 + TRH were elevated on d 1 and increased further on d 8 in the critically ill animals. Mean TSH concentrations were identical in both groups on d 1 and 8, in the face of dramatically suppressed plasma T(4) and T(3) concentrations in the critically ill animals. PRL secretion was impaired in the critically ill animals exclusively on d 8. TSH and PRL responses to GHRP-2 and TRH were increased only on d 1. In conclusion, this rabbit model of acute and prolonged critical illness reveals several of the clinical, biochemical, and endocrine manifestations of the human counterpart.
Study Information
pubmed
2002
10.1210/endo.143.3.8664